A0A075B6Z1_HUMAN Loading...

T cell receptor alpha joining 20 AlphaSync

AlphaFold DB , UniProt , Accession A0A075B6Z1, Species HUMAN (Homo sapiens, Human), Gene TRAJ20, Length 19 aa.

						>A0A075B6Z1_HUMAN|A0A075B6Z1|TRAJ20
XSNDYKLSFGAGTTVTVRA
					

Structure Viewer

Loading PAE data...

(Predicted Aligned Error values between residue pairs)

Download Structure AlphaSync Parameters PDB PAE Table

Site	Residue	pLDDT	pLDDT confidence	pLDDT₁₀	pLDDT10 confidence	SASA	SASA [Å²]	SASA₁₀	SASA10 [Å²]	RSA	RSA unformatted	RSA₁₀	RSA10 unformatted	Surface	Surface10 (not used)	Disorder (not used)	Disorder	Sec. str.	Secondary structure	Isomer	Phi (φ)	Psi (ψ)	Omega (ω)	Chi 1 (χ₁)	Chi 2 (χ₂)	Chi 3 (χ₃)	Chi 4 (χ₄)	Chi 5 (χ₅)	Tau (τ)	Contacts (colored by PAE)	Contact details
1	X	72.4	Confident	87	Confident	117 Å²	117	125.5 Å²	125.5	100%	1.206	75%	0.752	S	S	*	*				0	130.4	0	0	0	0	0	0	107.4	N3	G1-N3 PolarHBondContact O-N 3.46Å
2	S	79	Confident	87.9	Confident	105 Å²	105	122 Å²	122	73%	0.734	76%	0.761	S	S	*	*			trans	-64.9	117.6	172.1	-175.7	0	0	0	0	107.3	D4	S2-D4 PolarHBondContact O-N 3.19Å; S2-D4 PolarHBondContact OG-OD1 3.4Å
3	N	79.2	Confident	88.7	Confident	108 Å²	108	118.5 Å²	118.5	58%	0.578	74%	0.739	S	S	*	*			trans	-80.8	98.7	174.4	-69	-25.5	0	0	0	106.6	X1 Y5	G1-N3 PolarHBondContact O-N 3.46Å; N3-Y5 HydrophobicContact CB-CD2 4.09Å; N3-Y5 HydrophobicContact CB-CE1 4.24Å; N3-Y5 HydrophobicContact CB-CE2 3.49Å; N3-Y5 VanDerWaalsContact CB-CE2 3.49Å; N3-Y5 PolarHBondContact ND2-OH 3.42Å; N3-Y5 WeakPolarHBondContact O-CD2 3.33Å; N3-Y5 PolarHBondContact O-N 3.05Å
4	D	83.1	Confident	89.2	Confident	142 Å²	142	118.9 Å²	118.9	76%	0.759	74%	0.741	S	S	*	*			trans	-72	81.1	178.4	-65	-22.2	0	0	0	109.5	S2 K6	S2-D4 PolarHBondContact O-N 3.19Å; S2-D4 PolarHBondContact OG-OD1 3.4Å; D4-K6 PolarHBondContact O-N 3.39Å
5	Y	84.2	Confident	89.6	Confident	200 Å²	200	116.7 Å²	116.7	78%	0.784	73%	0.726	S	S	*	*			trans	-69.5	97.1	176.1	-63.4	-71.9	0	0	0	109.6	N3	N3-Y5 HydrophobicContact CB-CD2 4.09Å; N3-Y5 HydrophobicContact CB-CE1 4.24Å; N3-Y5 HydrophobicContact CB-CE2 3.49Å; N3-Y5 VanDerWaalsContact CB-CE2 3.49Å; N3-Y5 PolarHBondContact ND2-OH 3.42Å; N3-Y5 WeakPolarHBondContact O-CD2 3.33Å; N3-Y5 PolarHBondContact O-N 3.05Å
6	K	88.1	Confident	90.1	Very high	175 Å²	175	116.4 Å²	116.4	76%	0.761	72%	0.724	S	S	*	*			trans	-88.1	124.4	174	-176.4	174.4	178.3	179.1	0	110.5	D4 S8	D4-K6 PolarHBondContact O-N 3.39Å; K6-S8 PolarHBondContact O-N 3.25Å
7	L	91.2	Very high	90.3	Very high	143 Å²	143	117.5 Å²	117.5	75%	0.749	73%	0.729	S	S	*	*			trans	-71.9	123	165.3	-58.7	177.7	0	0	0	108.7	F9	L7-F9 HydrophobicContact CB-CE2 4.14Å; L7-F9 HydrophobicContact CB-CZ 4.12Å
8	S	93.7	Very high	90.5	Very high	96 Å²	96	123.6 Å²	123.6	67%	0.671	74%	0.736	S	S	*	*			trans	-120	134.9	-178.8	-54.6	0	0	0	0	109.1	K6	K6-S8 PolarHBondContact O-N 3.25Å
9	F	94.2	Very high	90.7	Very high	131 Å²	131	126.2 Å²	126.2	58%	0.575	77%	0.773	S	S	*	*			trans	-122.9	138.5	180	-55.3	-74.8	0	0	0	109.7	L7 T13 V15	L7-F9 HydrophobicContact CB-CE2 4.14Å; L7-F9 HydrophobicContact CB-CZ 4.12Å; F9-T13 HydrophobicContact CG-CG2 4.4Å; F9-T13 HydrophobicContact CB-CG2 4.15Å; F9-T13 HydrophobicContact CD1-CG2 3.89Å; F9-V15 HydrophobicContact CD1-CG2 3.9Å; F9-V15 HydrophobicContact CD2-CG2 4.06Å; F9-V15 HydrophobicContact CE1-CG2 3.91Å; F9-V15 HydrophobicContact CE2-CG2 4.09Å; F9-V15 HydrophobicContact CG-CG2 3.97Å; F9-V15 HydrophobicContact CZ-CG2 4.01Å
10	G	95.9	Very high	90.7	Very high	52 Å²	52	126.2 Å²	126.2	54%	0.536	77%	0.773	S	S	.	*			trans	-92	175.3	-178.7	0	0	0	0	0	113.1	G12 T13	G10-G12 PolarHBondContact O-N 3.29Å; G10-T13 WeakPolarHBondContact O-CB 3.14Å; G10-T13 PolarHBondContact O-N 3.21Å; G10-T13 PolarHBondContact O-OG1 2.85Å; G10-T13 VanDerWaalsContact O-OG1 3.05Å
11	A	96.6	Very high	90.7	Very high	111 Å²	111	126.2 Å²	126.2	92%	0.917	77%	0.773	S	S	*	*	T	Hydrogen-bonded Turn	trans	-56	137	175.1	0	0	0	0	0	111.3	T13	A11-T13 VanDerWaalsContact C-N 3.28Å; A11-T13 PolarHBondContact O-N 2.95Å
12	G	97.8	Very high	91.7	Very high	84 Å²	84	126.7 Å²	126.7	87%	0.866	75%	0.749	S	S	*	*	T	Hydrogen-bonded Turn	trans	77.3	3.1	-178.9	0	0	0	0	0	115.6	G10	G10-G12 PolarHBondContact O-N 3.29Å
13	T	97.5	Very high	92.4	Very high	77 Å²	77	128 Å²	128	47%	0.472	75%	0.75	S	S	.	*	P	Polyproline II helix	trans	-81.2	122.5	176.5	-56.1	0	0	0	0	111.1	F9 G10 A11 V15	F9-T13 HydrophobicContact CG-CG2 4.4Å; F9-T13 HydrophobicContact CB-CG2 4.15Å; F9-T13 HydrophobicContact CD1-CG2 3.89Å; G10-T13 WeakPolarHBondContact O-CB 3.14Å; G10-T13 PolarHBondContact O-N 3.21Å; G10-T13 PolarHBondContact O-OG1 2.85Å; G10-T13 VanDerWaalsContact O-OG1 3.05Å; A11-T13 VanDerWaalsContact C-N 3.28Å; A11-T13 PolarHBondContact O-N 2.95Å; T13-V15 HydrophobicContact CG2-CG2 4.45Å
14	T	96.4	Very high	93.3	Very high	124 Å²	124	129.3 Å²	129.3	76%	0.761	76%	0.761	S	S	*	*	P	Polyproline II helix	trans	-95.5	120.2	173.3	-58	0	0	0	0	110.3	T16	T14-T16 HydrophobicContact CG2-CG2 4.34Å
15	V	95.5	Very high	93.9	Very high	86 Å²	86	128.4 Å²	128.4	52%	0.521	76%	0.761	S	S	.	*	P	Polyproline II helix	trans	-100.9	124.2	175.7	-178.5	0	0	0	0	109.3	F9 T13	F9-V15 HydrophobicContact CD1-CG2 3.9Å; F9-V15 HydrophobicContact CD2-CG2 4.06Å; F9-V15 HydrophobicContact CE1-CG2 3.91Å; F9-V15 HydrophobicContact CE2-CG2 4.09Å; F9-V15 HydrophobicContact CG-CG2 3.97Å; F9-V15 HydrophobicContact CZ-CG2 4.01Å; T13-V15 HydrophobicContact CG2-CG2 4.45Å
16	T	96.5	Very high	94.6	Very high	112 Å²	112	123.3 Å²	123.3	69%	0.687	76%	0.759	S	S	*	*			trans	-114.9	125.5	174.6	59	0	0	0	0	110	T14	T14-T16 HydrophobicContact CG2-CG2 4.34Å
17	V	94.6	Very high	95.1	Very high	135 Å²	135	119.3 Å²	119.3	82%	0.818	76%	0.759	S	S	*	*			trans	-99.8	132.1	171.9	-178.8	0	0	0	0	108.3
18	R	93.9	Very high	95.5	Very high	226 Å²	226	117.3 Å²	117.3	85%	0.853	76%	0.76	S	S	*	*			trans	-105.1	135.1	167.4	-61.4	-178	-178.2	-161.5	-0.2	107
19	A	93.1	Very high	95.6	Very high	174 Å²	174	119.3 Å²	119.3	100%	1.438	77%	0.768	S	S	*	*			trans	-63.4	0	171.5	0	0	0	0	0	110.7

Retrieved 19 of 19 residues in 13.4 ms (Link to these results)

U.S. Privacy Notice - Disclaimer / Registrations / Copyright Statement - Linking Policy - Notice of Privacy Practices (HIPAA) - Notice of Non‑Discrimination
© Copyright 2026 St. Jude Children's Research Hospital, a not-for-profit, section 501(c)(3).